In vivo drug target discovery: Identifying the best targets from the genome

Current Opinion in Biotechnology

Volumn 12, Issue 6, 2001, Pages 626-631

  Walke, D Wade ^a   Han, Chunsheng ^a   Shaw, Joseph ^a   Wann, Elisabeth ^a   Zambrowicz, Brian ^a   Sands, Arthur ^a  

^a LEXICON PHARMACEUTICALS INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG;

DRUG ACTIVITY; DRUG INDUCED DISEASE; DRUG TARGETING; GENE FUNCTION; GENE SEQUENCE; GENE TARGETING; GENETIC SCREENING; GENOME ANALYSIS; HUMAN; IN VIVO STUDY; KNOCKOUT GENE; KNOCKOUT MOUSE; MAMMAL; NONHUMAN; PHARMACEUTICS; PHENOTYPE; PHYSIOLOGY; PREDICTION; PRIORITY JOURNAL; REVIEW;

ANIMALS; AUTOMATION; COMPUTATIONAL BIOLOGY; DRUG INDUSTRY; GENE LIBRARY; GENETIC TECHNIQUES; GENOME; HUMANS; MICE; MICE, KNOCKOUT; PHENOTYPE; SOFTWARE;

MAMMALIA;

EID: 0035711462     PISSN: 09581669     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0958-1669(01)00271-3     Document Type: Review

References (24)

1. Too many targets, not enough target validation
2. A revolution in R&D: The impact of genomics
3. The impact of genomics on drug development
4. Transgenic knockouts as part of high-throughput, evidence-based target selection and validation strategies
5. Generating mice with targeted mutations
6. The interferon system and interferon regulatory factor transcription factors - Studies from gene knockout mice
7. Murine tumor suppressor models
8. Dissecting the role of the serotonin system in neuropsychiatric disorders using knockout mice
9. KOs and organisation of peptidergic feeding behavior mechanisms
10. Mouse models of hyperlipidemia and atherosclerosis
11. Genetic models of obesity and energy balance in the mouse
12. Initial sequencing and analysis of the human genome
13. The sequence of the human genome
14. Construction of gene targeting vectors from λKOS genomic libraries
15. Disruption and sequence identification of 2,000 genes in mouse embryonic stem cells
16. Osteopetrosis and osteoporosis: Two sides of the same coin
17. Cathepsin Kl: Cathepsin K and the design of inhibitors of cathepsin K
18. Impaired osteoclastic bone resorption leads to osteopetrosis in cathepsin-K-deficient mice
19. Targeted disruption of the melanocortin-4 receptor results in obesity in mice
20. Inactivation of the mouse melanocortin-3 receptor results in increased fat mass and reduced lean body mass
21. Role of the melanocortin-4 receptor in metabolic rate and food intake in mice
22. The lac operator-repressor system is functional in the mouse
23. Continuous fatty acid oxidation and reduced fat storage in mice lacking acetyl-CoA carboxylase 2